China 
Africa 
Explore chapters and articles related to this topic
Study of Machine Learning Classification Algorithms to Predict Accuracy and Performance of Liver Disease
Published in Rajesh Singh, Anita Gehlot, P.S. Ranjit, Dolly Sharma, Futuristic Sustainable Energy and Technology, 2022
Pawan Kumar Singh, Virendra Pal Singh, Pankaj Sharma, Durgesh Narayan
The situation in which the liver is infected and does not work in proper order is name as liver disease [2]. There are various reasons which can cause liver diseases. Some of the top causes which lead to serious liver conditions are mentioned below: Infections: An infection can sometimes harm the liver. Viral hepatitis including hepatitis A, B and C is the most frequent infection.Immune system difficulties: These problems happen when the body’s immune system is disordered and attacks the liver. Hepatitis autoimmune, bile cholangitis main and primary cholangitis are causes of the inflammation of the liver.Cancer and tumours: Liver cancer (sometimes called hepatocellular carcinoma), cancer of the bile duct, liver cell adenoma is some of the malignancies that cause substantial liver damage.Conditions You Inherit: Some of the disorders in a person are inherited from his parents. Hemochromatosis, Hyperoxaluria, Wilson’s disease, Alpha-1 antitrypsin deficiency are such inherited disorders which can cause liver diseases.Other Causes of Liver Disease: Alcohol abuse, drug overdoses, non-alcoholic fatty liver disease (NAFLD) are some other reasons which can inflame the liver
Current and Future Prospects in the Treatment of Chronic Obstructive Pulmonary Disorders
Published in Suvardhan Kanchi, Rajasekhar Chokkareddy, Mashallah Rezakazemi, Smart Nanodevices for Point-of-Care Applications, 2022
Manu Sharma, Aishwarya Rathore, Sheelu Sharma, Kakarla Raghava Reddy, Veera Sadhu
Healthcare officials often suggest the patient undergo a certain test to ensure the disease with which the patient is suffering (Figure 7.5). The first and foremost test prescribed by the healthcare professional is the lung function test which is also called a spirometry test. This test indicates how well the lung functions. The patient breathes out into the mouthpiece of the machine after inhaling the bronchodilator. The spirometer would measure the air volume one breathes out per second and also the total air amount one breathes out. Apart from spirometry other lung function tests include measurement of lung volumes, diffusing capacity, and pulse oximetry [9]. Similar to this is a peak flow test that measures how fast a person breathes out. Blood oxygen tests can determine the level of oxygen in the blood sample. In this test, a peg-like device is attached to the finger of the patient and it measures the oxygen level in the blood. A simple blood test can also be done to determine if the patient has polycythemia, alpha-1-antitrypsin deficiency, etc. [10]. A phlegm (sputum) sample can also be tested to check for signs of a chest infection.
Effects of Whole Body Vibration in Patients with Chronic Obstructive Lung Disease
Published in Redha Taiar, Christiano Bittencourt Machado, Xavier Chiementin, Mario Bernardo-Filho, Whole Body Vibrations, 2019
Dulciane N. Paiva, Patrícia E. M. Marinho, Litiele E. Wagner, Marciele S. Hopp, Armèle Dornelas de Andrade
Chronic Obstructive Pulmonary Disease (COPD) is the fourth most frequent cause of mortality worldwide, without a tendency in decreasing or stabilizing its epidemiological growth, with the prospect of becoming the third cause of mortality in the world by 2020 (Vogelmeier et al., 2017; Mendes et al., 2011; de Sousa et al., 2011). Smoking is the main risk factor for the onset of COPD; in addition to cigarette smoke, occupational dust, chemical irritants, environmental pollution, low socioeconomic status, and severe respiratory infections in childhood constitute other factors. Some individual factors also contribute to COPD development such as bronchial hyper-responsiveness, malnutrition, prematurity, and recurrent respiratory infections. The genetic factor determined by alpha-1 antitrypsin deficiency occurs in about 3%–10% of the caucasian population, and may also be associated with the occurrence of COPD (Vogelmeier et al., 2017; de Sousa et al., 2011; Miravitles, 2004).
The roadmap towards cure of chronic hepatitis B virus infection
Published in Journal of the Royal Society of New Zealand, 2022
Translation inhibitors can silence production of disease-associated proteins and enzymes by intervening at the transcript level (mRNA) (Figure 3). Target diseases include both inherited conditions associated with unwanted gene products including hypercholesteraemia, familial amyloid polyneuropathy, PNH, acute intermittent porphyria and alpha-1-antitrypsin deficiency and acquired diseases such as chronic bacterial or viral infections.